191 related articles for article (PubMed ID: 6749702)
1. Long-term antihypertensive therapy with guanfacine.
Szám I; Holló J
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effect of guanfacine: long-term 'once-a-day' treatment and sudden withdrawal.
Szám I; Holló J
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():469s-471s. PubMed ID: 7032828
[TBL] [Abstract][Full Text] [Related]
3. [Estulic in the long-term treatment of hypertension].
Rhomberg F
Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668
[TBL] [Abstract][Full Text] [Related]
4. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
5. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
[TBL] [Abstract][Full Text] [Related]
6. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of guanfacine in essential hypertension.
Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
[TBL] [Abstract][Full Text] [Related]
8. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
[TBL] [Abstract][Full Text] [Related]
10. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
Rosenthal J; Jäger H
MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
[TBL] [Abstract][Full Text] [Related]
11. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
12. [Clinical pharmacology of the antihypertensive action of guanfacine].
Safar M; Weiss Y; Georges D
Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
[TBL] [Abstract][Full Text] [Related]
13. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
15. Long term comparative study of guanfacine and alpha-methyldopa in essential hypertension.
Rengo F; Ricciardelli B; Volpe M; Trimarco B; Saccà L; Condorelli M
Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):281-91. PubMed ID: 6996627
[TBL] [Abstract][Full Text] [Related]
16. Guanfacine: effects of long-term treatment and withdrawal.
Reid JL; Zamboulis C; Hamilton CA
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
[TBL] [Abstract][Full Text] [Related]
17. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
18. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
Rhomberg F; Widler J
Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
Coves MJ; Gomis R; Casamitjana R; Lienas V; Vilaradell E
J Med; 1989; 20(3-4):291-6. PubMed ID: 2572660
[TBL] [Abstract][Full Text] [Related]
20. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
